BioSpace News Archive

The Beijing-based biotech will use the Series B funds to further their hematopoietic disease and cancer therapies pipeline and expand team.

Kerecis®, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, has received a grant of almost $600,000 from the U.S. Department of Defense (DoD).

Aural Analytics, Inc., an industry leading speech neuroscience and speech analytics technology company, announced today it has partnered with Signant Health (Signant) to integrate its A2E™ mobile application SDK and Web API across Signant Health’s Rater Station™ and TrialMax® training, data quality monitoring and eCOA solutions

Cambridge Research & Development (CRD – https://cambridgerad.com/ ) recently announced a licensing opportunity involving its proprietary Self-Sanitizing Door Control System (SSDCS). The SSDCS is a door-opening system tha

Researchers from Battelle, Rochester Institute of Technology, and the University of New Hampshire to Collaborate on Project

Lassogen , a company dedicated to developing lasso peptides as an entirely new therapeutic modality, today announced that it has raised $4.5 million in an oversubscribed seed round of funding led by Playground Global with participation from Better Ventures, First In

Dr. Deepak Chopra, Kelly LeVeque & More Lead Symposium “Leaving Normal Behind: How to Thrive in Our New World” [13-October-2020] NEW YORK , Oct. 13, 2020 /PRNewswire/ -- Institute for Integrative Nutrition (IIN), the world’s largest and most reputable institution focused on nutrition and health coaching, will host IINVirtual’s “Leaving Normal B

Collaborations with European and Canadian suppliers for large-scale ramp-up of opaganib manufacturing further strengthen s manufacturing capabilities and capacity , in preparation for potential emergency use applications -- Enrollment in the g lobal Phase 2/3 COVID-19 study with opaganib is advancing rapidly following approval s in 6 countries -- U.S . Phase 2 COVID-19 study with opaganib

Medtronic plc (NYSE:MDT) today released its fiscal year 2020 (FY20) Integrated Performance Report: Putting Purpose Into Action . The report shares the company’s approach to its most significant environmental, social, a

InterVenn Biosciences today announced it has identified marked differences in the glycoproteomic profile of patients who became seriously ill with COVID-19, as compared to individuals who had also been infected with the SARS-CoV-2 virus but experienced no or minimal symptoms.